[pro_ad_display_adzone id="15"]

Kaneka Receives NPN License Approval for Intensive G.I.

By on April 30, 2020

Newark, CA  — Kaneka Americas Holding, Inc., achieves Health Canada Class III approval for Floradapt™ Intensive G.I. under the Natural Health Products Directorate (NHPD) as identified by the Natural Product Number (NPN) 80096250.  Floradapt Intensive G.I. is a patented probiotic that has been evaluated by Health Canada and found to be safe, effective and of high quality under the recommended conditions of use. 

IGI 863x1024 - Kaneka Receives NPN License Approval for Intensive G.I.

Disorders of the gut are prevalent in the Canadian population. According to the Canadian Digestive Health Foundation, it is estimated that Canada has the highest prevalence of Irritable Bowel Syndrome in the world at 18% versus 11% of the population found globally. Of those that suffer with this gastrointestinal disorder, 70% indicate that their symptoms interfere with their everyday life, and 40-60% of those subjects experience psychological symptoms, anxiety and depression. The NPN License Approval for Floradapt™ Intensive G.I. allows for the following claims:

•  Helps to improve gut-related anxiety /discomfort in 6 weeks*

•  Helps to improve quality of life in patients with diarrhea-predominant Irritable Bowel Syndrome*

•  Could promote a favorable gut flora*

•  Helps support intestinal / gastrointestinal health*

•  Source of probiotics*

   *Claims not valid for the US Market

Mike Kolifrath, Vice President, Sales and Marketing of the Probiotics Division at Kaneka, commented, “Intensive gastro-intestinal disorders can be quite debilitating to those afflicted with this condition. Our Intensive G.I. stands on a foundation of two published clinical trials assessing the impact of Floradapt Intensive G.I. on gut health on patients with Irritable Bowel Syndrome. These studies demonstrated that our formulation positively impacted gut health by improving gut-related anxiety/discomfort as well as promoted gut comfort.”

Floradapt™ Intensive G.I. is part of Kaneka’s Probiotic Portfolio, which is comprised of products based on a mechanistic approach to identify optimal strains for specific health applications. Our strain library collection has over 1,000+ strains strategically sourced from populations around the world with conserved microbiomes.  Floradapt™ includes strains for Cardio, Digestive, Intensive G.I., Gum Health, Mature Immune Defense, Vaginal Health, and Urinary Tract. Floradapt’s efficacy is rooted in its clinical strains and accomplished through a unique mechanism of action (MoA) not seen in other probiotic products.

About Kaneka

Kaneka is a leader in the development of scientifically based ingredients for the global nutrition industry, committed to promoting business development to provide solutions that support healthy and energetic lives. For more information, visit us at http://www.floradapt.com.